Low-dose HDACi potentiates anti-tumor activity of macrophages in immunotherapy

Xiaolei Li1, Hanren Dai1, Hua Wang1

  • 1Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Oncoimmunology
|June 14, 2021
PubMed

Related Concept Videos